Related Experiment Video
Updated: Nov 24, 2025
07:57
Electrospinning Fundamentals: Optimizing Solution and Apparatus Parameters
Published on: January 21, 2011
65.4K
Electrospinning for healthcare: recent advancements
Karolina Dziemidowicz1, Qingqing Sang, Jinglei Wu
1UCL School of Pharmacy, University College London, 29-39 Brunswick Square, London WC1N 1AX, UK. g.williams@ucl.ac.uk.
Journal of Materials Chemistry. B
|December 28, 2020
Summary
Electrospinning creates nano- to micron-scale polymer fibers for biomedical uses like drug delivery and tissue engineering. Translating this technology to the clinic requires large-scale production under Good Manufacturing Practice standards.
Area of Science:
- Biomaterials Science and Engineering
- Nanotechnology
- Medical Devices
Background:
- Electrospinning is a versatile technique for producing polymer fibers at the nano- to micron-scale.
- These fibers have shown significant promise in various biomedical applications, including drug delivery, diagnostic imaging, theranostics, and tissue engineering.
- The ability to incorporate diverse functional components (small molecule drugs, biologics, nanoparticles) and create complex architectures makes electrospun materials highly adaptable.
Purpose of the Study:
- To provide a perspective on the potential applications of electrospinning in biomedicine.
- To highlight the challenges and considerations for translating electrospun materials from laboratory research to clinical practice.
- To summarize current challenges and future directions in the field of biomedical electrospinning.
Main Methods:
- Review of existing literature on electrospinning techniques and their biomedical applications.
- Analysis of the requirements for clinical translation, focusing on scalability and regulatory compliance (Good Manufacturing Practice).
- Identification of key challenges and future research opportunities.
Main Results:
- Electrospinning enables the incorporation of a wide range of therapeutic agents and nanoparticles into fibrous materials.
- Complex fiber architectures can be fabricated to control release kinetics and cellular interactions.
- Successful clinical translation necessitates addressing challenges in large-scale manufacturing and adherence to Good Manufacturing Practice standards.
Conclusions:
- Electrospinning offers a promising platform for advanced biomedical applications due to its versatility and ability to create functional nanomaterials.
- Significant hurdles remain in scaling up production and meeting stringent regulatory requirements for clinical use.
- Future research should focus on optimizing manufacturing processes and demonstrating clinical efficacy to facilitate broader adoption.
